AngioDynamics To Participate in Panel Discussion at RBC 2008 Healthcare Conference

QUEENSBURY, N.Y., Dec 04, 2008 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that Eamonn Hobbs, its President and CEO, will participate in a panel discussion entitled "Adaptation and Transformation: Overcoming The Obstacles To Growth" at the RBC 2008 Healthcare Conference. The panel is scheduled for Thursday, December 11, 2009 at 10:00 a.m. ET.

Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company's website at: www.angiodynamics.com.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation and irreversible electroporation resection systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

SOURCE: AngioDynamics, Inc.

AngioDynamics, Inc.
Company Contact:
D. Joseph Gersuk, 800-772-6446 x1608 (CFO)
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Investor Relations Contacts:


Doug Sherk/Jenifer Kirtland, 415-896-6820
jkirtland@evcgroup.com
Media Contact:
Chris Gale, 646-201-5431
cgale@evcgroup.com